1 / 41

beth rutkowski, m.p.h.finnertyucla pacific southwest addiction technology transfer center

bernad
Download Presentation

beth rutkowski, m.p.h.finnertyucla pacific southwest addiction technology transfer center

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Beth Rutkowski, M.P.H. finnerty@ucla.edu Pacific Southwest Addiction Technology Transfer Center UCLA Integrated Substance Abuse Programs

    2. Consequences to the Brain

    6. PET Scan of Long-Term Impact of Methamphetamine on the Brain

    7. Decreased dopamine transporter binding in METH users resembles that in Parkinson’s Disease If DAT is decreased in young METH users (almost to that observed in Parkinson’s Disease), and DAT decreases with age, may we see an increase in the number of Parkinsonian patients over time? If DAT is decreased in young METH users (almost to that observed in Parkinson’s Disease), and DAT decreases with age, may we see an increase in the number of Parkinsonian patients over time?

    9. Cognitive and Memory Effects

    10. Differences between Stimulant and Comparison Groups on tests requiring perceptual speed

    11. Memory Difference between Stimulant and Comparison Groups

    12. Longitudinal Memory Performance

    16. How much does the brain heal?

    17. PET Scan of Long-Term Meth Brain Damage

    19. Partial Recovery of Brain Metabolism in Methamphetamine (METH) Abuserafter Protracted Abstinence

    20. Acute and Long-Term Effects of the Methamphetamine Abuse A Quick Review:

    21. MethamphetamineAcute Physical Effects Increases Heart rate Blood pressure Pupil size Respiration Sensory acuity Energy

    22. MethamphetamineAcute Psychological Effects Increases Confidence Alertness Mood Sex drive Energy Talkativeness Decreases Boredom Loneliness Timidity

    23. Long-Term Effects of Methamphetamine

    24. MethamphetamineChronic Physical Effects Tremor Weakness Dry mouth Weight loss Cough Sinus infection

    25. MethamphetamineChronic Psychological Effects Confusion Concentration Hallucinations Fatigue Memory loss Insomnia

    26. Local Infections

    28. Faces of Methamphetamine Images courtesy Multnomah County Sheriff’s Office

    29. Meth Mouth Rotting of teeth around the gums Process may involve lack of saliva production or qualities of methamphetamine or its constituents Smoking/snorting problems Bruxism; Rampant caries

    30. Infective Endocarditis (i.e., staphylococcus aurcus) Frequent among IDUs 8-16% of hospital admissions for IDUs Organism colonizes skin, also includes drug, adulterants, packaging, fluids Occurs mostly to right side of heart Most common symptom is chest pain, cough, fever, chills, arthralgia Antibiotic treatment or surgery Infective Endocarditis (i.e., staphylococcus aurcus) Frequent among IDUs 8-16% of hospital admissions for IDUs Organism colonizes skin, also includes drug, adulterants, packaging, fluids Occurs mostly to right side of heart Most common symptom is chest pain, cough, fever, chills, arthralgia Antibiotic treatment or surgery

    31. MATRIX MODEL TREATMENT

    32. STAGES OF RECOVERY - STIMULANTS

    37. Successful Outpatient Treatment Predictors Durations over 90 days (with continuing care for another 9 months). Techniques and clinic practices that improve treatment retention are critical. Treatment should include 3-5 clinic visits per week for at least 90 days.

    38. Successful Outpatient Treatment Predictors Employ evidence-based practices [i.e., CBT, CM, Community Reinforcement Approach, Motivational Interviewing, Matrix Model]. Family involvement and 12-step programs appear to improve outcome. Urine testing (at least weekly is recommended)

    39. Special treatment consideration should be made for the following groups of individuals: Female MA users (higher rates of depression; very high rates of previous and present sexual and physical abuse; responsibilities for children). Injection MA users (very high rates of psychiatric symptoms; severe withdrawal syndromes; high rates of hepatitis). MA users who take MA daily or in very high doses.

    40. Special treatment consideration should be made for the following groups of individuals: Homeless, chronically mentally ill and/or individuals with high levels of psychiatric symptoms at admission. Individuals under the age of 21. Gay men (at very high risk for HIV and hepatitis).

More Related